교육 프로그램

2024 Program

2024 Program
Lecture Topic Speaker Affiliation
Sesson 1 Introduction to the Korean Dementia Association’s recommendation for the use of Lecanemab-1 Seol-Heui Han  Konkuk University
Background of recommendation development and considerations for selecting appropriate patients treated by Lecanemab Kee Hyung Park Gachon University Gil Medical Center
Test method to select patients suitable for lecanemab use Seong-Ho Koh Hanyang University Guri Hospital
Preparation for use of lecanemab in clinical practice Seong Hye Choi Inha University Hospital
Q & A
Sesson 2 Introduction to the Korean Dementia Association’s recommendation for the use of Lecanemab-2 Seung Hyun Kim Hanyang University Hospital
Method of monitoring patients receiving lecanemab Geon Ha Kim Ewha Womans University Mokdong Hospital
Realistic problems that can occur in actual outpatient settings Dong Won Yang The Catholic University of Korea Seoul St. Mary’s Hospital
Considerations of other situations in which lecanemab may be useful So Young Moon Ajou University Hospital
Q & A
Sesson 3 ARIA
How to easily diagnose ARIA Won-Jin Moon Konkuk University
Q & A
Sesson 4 Experience in Japan SangYun Kim Seoul National University Bundang Hospital
Lecanemab in Japna: Current status and Experience of Japan; including policies and necessary facilities Atsushi Iwata Tokyo Metropolitan Institute for Geriatrics and Gerontology
Q & A
Sesson 5 General discussion KunWoo Park Korea University Anam Hospital
General discussion

2023 Program

2023 Program
Lecture Topic Speaker Affiliation
Sesson 1 Is the recently developed treatment for Alzheimer's disease worth using? Seol-Heui Han  Konkuk University
8:30~9:00 Clinical effect of Lecanemab and Donanemab Seong Hye Choi Inha University Hospital
9:00~9:20 Is ARIA controllable side effect? Hee-Jin Kim Hanyang University Hospital
Sesson 2 What is being done to ensure proper use of new AD treatments? Dong Won Yang The Catholic University of Korea Seoul St. Mary’s Hospital
9:20~9:40 Review of usage guidelines for Aducanumab and Lecanemab Jae-Sung Lim Asan Medical Center
9:40~10:00 America prepares for new AD treatments: ALZ-NET, Preparedness for Newly Approved DMT Drugs in US Alzheimer's Association, US Alzheimer's Association, US
10:00~10:20 Q & A
Sesson 3 What should we prepare for domestic use of new treatments? SangYun Kim Seoul National University Bundang Hospital
10:40~10:55 What are the appropriate guidelines for domestic amyloid and tau PET? Chan-Nyoung Lee Korea University Anam Hospital
10:55~11:10 Is it impossible to replace imaging tests with cerebrospinal fluid tests in Korea? Sun Ah Park Ajou University Hospital
11:10~11:25 What level has blood-based testing reached? Seong-Ho Koh Hanyang University Guri Hospital
11:25~11:40 What are the expected changes to the healthcare system? Hojin Choi Hanyang University Guri Hospital
Sesson 4 Panel discussion: Is early domestic approval of new drugs necessary? Kee Hyung Park Gachon University Gil Medical Center 
11:40~12:30 Panel discussion:
Senior Health Department, Ministry of Health and Welfare, Korea Dementia Association, Central Dementia Center, Pharmaceutical company

2022 Program

Will be updated!

2021 Program

Will be updated!

2020 Program

Will be updated!

2019 Program

Will be updated!

2018 Program

Will be updated!

2017 Program

Will be updated!

2016 Program

Will be updated!

2015 Program

Will be updated!

2014 Program

Will be updated!

2013 Program

Will be updated!

2012 Program

Will be updated!

2011 Program

Will be updated!

2010 Program

Will be updated!

2009 Program

Will be updated!

2008 Program

Will be updated!

2007 Program

Will be updated!

2006 Program

Will be updated!

2005 Program

Will be updated!

2004 Program

Will be updated!

2003 Program

Will be updated!

2002 Program

Will be updated!

2001 Program

Will be updated!

2000 Program

Will be updated!

1999 Program

Will be updated!

1998 Program

Will be updated!